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Available online 11 April 2016Background: Plasmodium has a complex biology including the ability to interact with host signals modulating their
function through cellular machinery. Tumor necrosis factor (TNF) elicits diverse cellular responses including effects
inmalarial pathology and increased infected erythrocyte cytoadherence. As TNF levels are raised during Plasmodium
falciparum infection we have investigated whether it has an effect on the parasite asexual stage.
Methods: Flow cytometry, spectroﬂuorimetric determinations, confocal microscopy and PCR real time quantiﬁca-
tions were employed for characterizing TNF induced effects and membrane integrity veriﬁed by wheat germ
agglutinin staining.
Results: TNF is able to decrease intracellular parasitemia, involving calcium as a second messenger of the pathway.
Parasites incubated for 48 hwith TNF showed reduced erythrocyte invasion. Thus, TNF induced rises in intracellular
calciumconcentration,whichwere blockedbyprior additionof the purinergic receptor agonists KN62andA438079,
or interfering with intra- or extracellular calcium release by thapsigargin or EGTA (ethylene glycol tetraacetic acid).
Importantly, expression of PfPCNA1which encodes the Plasmodium falciparum Proliferating-Cell Nuclear Antigen 1,
decreased after P. falciparum treatment of TNF (tumor necrosis factor) or 6-Bnz cAMP (N6-benzoyladenosine-3′,5′-
cyclic monophosphate sodium salt).
Conclusions: This is potentially interesting data showing the relevance of calcium in downregulating a gene involved
in cellular proliferation, triggered by TNF.
General signiﬁcance: The data show that Plasmodiummay subvert the immunological system and use TNF for the
control of its proliferation within the vertebrate host.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Proliferating cell nuclear antigen-11. Introduction
Plasmodium has a complex life cycle including the ability to interact
with host signals, modulating their function through cellular machinery
and membrane receptors. Signal transduction inside Plasmodium has
been shown as a major mechanism to control parasite development
[1–3]. Plasmodium infection remodels the cytoskeleton network in
infected erythrocyte (IE) [4] and communication has been shown to
occur by exosome-like vesicles sensitive to actin ﬁlaments andmicrotu-
bule inhibitors, which are released into culture supernatant and provide
means to respond to environmental changes [5].
Tumor necrosis factor (TNF) is a well-known pro-inﬂammatory
cytokine involved in host immunological responses that elicit
diverse cellular responses ranging from proliferation to activation of
apoptosis (reviewed in [6–8] and inhibitors of TNF production
reduced IE cytoadherence [9–10].In mammalian cells, the biological. This is an open access article underactivities of TNF are mediated by two distinct cell-surface receptors:
tumour-necrosis factor receptor-1 or 2 (TNFR1 and TNFR2). Ligand
binding to TNFR complexes induces intracellular signal transduction.
TNF induces an upstream activation of IƘƘB by phosphorylation,
ubiquitination and degradation of IƘB alpha. After phosphorylation,
NF-ƘB can be released and translocate to the nucleus, where it binds
to DNA sequences modulating gene expression [11]. The search for
molecular mechanisms involved in the TNF signaling cascade
showed its synthesis can be modulated at both transcriptional and
translational levels by the p38MAP kinase pathway [12–14]. Increas-
ing intracellular levels of cyclic adenosine monophosphate (cAMP)
can block TNF synthesis and cause activation of protein kinase A
preventing transcription of the gene encoding TNF and decrease in the
cytokine synthesis [15].
Receptors and pathways involved in TNF signaling have not been
reported in Plasmodium. In the host, TNF genotypes are associated
withmalaria clinical outcomes by changes in the cytokine plasma levels
[16] and apoptosis in CD4 T cells might be mediated by TNFR1 death
receptor via TNF pathway during Plasmodium vivax infection [17].the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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inﬂammatory response by inducing intracellular calcium rise, activates
transcription factors and leads to release of pro-inﬂammatory cytokines
[18–19] while the presence of putative purinergic receptor was
pharmacologically indicated in Plasmodium [20–21].
TNF was also shown to have effects on anti-microbial activities [22]
and high levels of this cytokine are associated with malarial pathology
[23]. Importantly, Plasmodium hepatic development is inhibited by
TNF [24–25] and the effect mediated by Interleukin (IL)-6 in response
to TNF stimulation [24–25].
During inﬂammation or infections the production of TNF is increased
and the present work evaluated if the intra-erythrocytic stage of
Plasmodium falciparum might also be modulated by this cytokine. Our
data show that TNF is able to reduce P. falciparum parasitemia through
a calcium-cAMP downstream signaling with, possibly, PCNA1 as a
target. The cross-talk between calcium and cAMP is a well-known
mechanism in mammalian cells and has been reported to occur in
P. falciparum infected cells [26] as well as P. chabaudi [27].
2. Material and methods
2.1. P. falciparum culture
P. falciparum parasites (3D7, A4 and ItG lines)were cultured in RPMI
1640 (Invitrogen) supplemented with 37.5 mM HEPES, 7 mM D-
glucose, 6 mM NaOH, 25/ml gentamicin sulphate, 2 mM L-glutamine
and 10% human serum and maintained in human erythrocytes under
a gas mixture of 5% O2, 5% CO2, and 90% N2. Previous to culture the
erythrocyte suspensions were washed 3 times in RPMI 1640 for
30 min followed by centrifugation at 8000 rpm. The top supernatant
layer was then aspirated to remove lymphocytes and platelets. Cultures
were maintained, synchronized by using 5% sorbitol and experiments
performed 24 h after synchronization. Procedures were approved by
the São Paulo University Ethics Committee.
2.2. Spectroﬂuorimetric determinations of intracellular calcium ﬂuxes
Isolated parasites were obtained by adding saponin (SIGMA) to a
ﬁnal concentration of 0.05% and the mixture was kept on ice for 5 min
to lyse the erythrocytes. Following centrifugation at 10,000 rpm at
4 °C for 10 min, erythrocyte ghosts were removed and the free parasite
pellets were washed twice using RPMI 1640 for 2 min at 10,000 rpm to
remove any insoluble material. Isolated P. falciparum (3D7) were
incubated for 60min at room temperature with the ﬂuorescent calcium
indicator Fluo-4/AM (5 μM) in MOPS buffer with Ca2+ (2 mM) and
1.8 mM probenecid. The cell suspension was then washed three times
[26]. For experiments without calcium, saponin isolated parasites
were incubated 1 min with EGTA (2 or 5 mM) in MOPS buffer without
calcium. Spectroﬂuorimeric measurements were performed in a
Shimadzu RF-5301 PC at 37 °C with parasites (108 cells ml−1) in a
1 ml cuvette. The ﬂuorescence wasmeasured continuously (acquisition
rate: every 0.5 s) for 550 s at 37 °C and TNF (0.25, 0.5, 1 or 10 ng/ml),
thapsigargin (10 μM) or control added during time course experiments.
Saponin isolated parasites were incubated with KN62 (10 μM) for
30 min or A438079 (5 μM) for 2 min followed by addition of TNF
(1 ng/ml). Excitation/emission wavelengths adjusted to 505/530 nm
for Fluo4-AM.
2.3. Immunoﬂuorescence
Immunoﬂuorescence was performed in saponin isolated
P. falciparum (3D7) parasites or IE after TNF (1 ng/ml) or PBS treatment
for 1 h at 37 °C. Cells were ﬁxed with paraformaldehyde 4% and glutar-
aldehyde 0.0075% for 30 min at room temperature, washed in PBS 3
times and incubated with DAPI (1:1000 in PBS) and washed 3 more
times in PBS. WGA (Wheat Germ Agglutinin) (10 μg/ml) was added for10 min at 37 °C followed by 3 ﬁnal PBS washes. Slides were sealed
with VectaShield (Vector). Image acquisitions were performed on a
confocal microscope and LSM Meta software using Plan-NeoFluor 63×
objective. The samples were excited at 585–615 nm and emission at
650 nm.
2.4. Invasion assay
Invasion was assessed using ﬂow cytometry analysis in P. falciparum
line 3D7 incubated for 48 h with TNF (1; 2 or 8 ng/ml) or PBS, and me-
dium replaced every 24 h. IE was then stained with dihydroethidine
(5 μg/ml) for 20 min at 37 °C and analysed by dot plots (side scatter
versus ﬂuorescence) of 105 cells. Dihydroethidine (DE) was excited
with a 488 nm Argon laser and ﬂuorescence emission was collected at
518–605 nm. Parameters subject to adjustment of the FACSCalibur
ﬂow cytometer were forward scatter (FSC) (log scale, E-1), SSC (log
scale, 269), FL-2 (log scale, 505). For all ﬂow cytometry experiments
initial gating was carried out with unstained erythrocytes to account
for erythrocyte autoﬂuorescence [28].
2.5. PCR real time (RT-PCR)
Total RNA from IE previously incubated for 1 h at 37 °C with 6-Bnz
cAMP (20 μM), TNF (1 ng/ml) or PBS for 1 h at 37 °C were extracted
by Trizol followed by DNAse I (20 U) treatment for 30min at room tem-
perature. RNA (0.5–1 μg) were transcribed using random primers and
Superscript II RNAaseH reverse transcriptase (Invitrogen). PCRwasper-
formed using Platinum Taq polymerase (Invitrogen) for 32 cycles and
the visualized on agarose gels. Real-time PCR was performed in tripli-
cate using Power SYBR-greenmix (Applied Biosystems). The sequences
of synthesized primers used in this work are provided in Supplemental
material Table 1 (PfPCNA1 and Seryl-tRNA synthetase control)
PlasmoDBnumber PF3D7_1361900 for Proliferating cell nuclear antigen
and PF07_0073 to serine — tRNA synthetase). The relative changes in
the amount of mRNA of target genes/seryltRNA synthetase were
determined by the formula 2ΔΔct or by the threshold cycle in absolute
numbers mRNA.
2.6. Endothelial cells
Humandermalmicrovascular endothelial cells (HDMEC)wereobtained
from commercial providers (Promocell) andmaintained in amanufacturer´
s recommended medium. Cells at passages 4–7 were used for all experi-
ments. Prior to experimentation cells were stimulated with TNF at a ﬁnal
concentration of 20 ng/ml overnight. This procedure stimulates the induc-
tion of ICAM-1 expression on the surface of the endothelial cells. Conﬂuent
HDMEC cells were detached from T25 ﬂask using Accutase followed by ad-
dition of HDMECmedia. Next, cells were centrifuged at 1200 rpm for 3min
and 1.5 × 106 cells per 100 μL used for ﬂow assays.
2.7. Flow based endothelial cell assays
Adhesion assays were performed as previously described [29].
Brieﬂy, HDMEC cell suspension was applied to endothelial biochips
(Vena8-Cellix) coated with ﬁbronectin (100 μg/ml), and allowed to
settle for 3 h at 37 °C to form a conﬂuent monolayer. HDMEC medium
was added to biochips every 30 min. A4 mid-trophozoite parasites
were prepared at 3% parasitemia and 2% haematocrit and pre-treated
with FK506 (1.5 or 6 μM), calyculin (2 or 10 μM), NFKKB inhibitor (1
or 2 μM) or DMSO (0.04%) for 30 min at 37 °C in binding buffer. After
ﬂowing binding medium through the microslide for 2 min, prepared
parasites were ﬂowed through at a wall shear stress of 0.05 Pa for
5 min, followed by a wash with binding buffer (2 min). Stationary
adherent parasites were counted in at least six ﬁelds along the slide
among 3–5 independent experiments. Results shown are compared to
DMSO treated culture.
Fig. 1. Effects of TNF on P. falciparum (3D7) erythrocyte invasion and Ca2+ concentration in isolated parasites. (A) Flow cytometry analyses of parasitemia in synchronized P. falciparum
(3D7) after 48 h of control or TNF (1, 2 and 8 ng/ml) treatment (* P b 0.05) (B) and intra-erythrocytic stages distribution. Bars represent the number of parasites expressed as percentage of
control or ring-trophozoites and schizonts (average) normalized by total parasitemia ± S.E.M. Cells were stained with dihydroethidine (5 μg/ml) and data (105 cells) were compared by
onewayANOVA andbyNewman–Keuls test. (C) Spectroﬂuorimetric analyses of Ca2+ concentration in isolatedparasites labelledwith Fluo4/AM(5 μM)after addition of TNF 0.25; 0.5; 1 or
10ng/ml (3.05 a.u.± 0.59,n=11, P=0.1536; 5.35 a.u.± 1.01,n=14, P=0.064; 9.476 a.u.±1.03;n=15, P=0.001 and7.91 a.u.±1.65, n=10, P=0.034, respectively). P valueswere
calculated by comparison with the PBS data (1.505 a.u. ± 0.07, n = 4). Bar graph means and SEM of at least three independent experiments. Arb. arbitrary. (D) Representative tracing of
Fluo4/AM changes over time by addition of TNF (0.25; 0.5; 1 and 10 ng/ml and PBS) in P. falciparum isolated parasites.
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ICAM-1 or CD36 (50 μg/ml) in PBS was spotted on 60-mm Petri
plates for 2 h at 37 °C in a humidiﬁed chamber, and used for binding as-
says with parasite cultures. PBS and BSA were used as negative controls
for binding. These plates were then blocked overnight with 1% BSA in
PBS at 4 °C. ItG parasites at 3% parasitemia and 1% haematocrit were
treated with FK506 (0.375, 0.75 or 1.5 μM) or DMSO (0.04%) for
30 min at 37 °C and added to the spotted plates in binding buffer. The
plates were carefully rotated every 10min for 1 h at 37 °C, and unbound
erythrocytes washed away with binding buffer. Bound erythrocytes
were ﬁxed in 1% glutaraldehyde for 1h at room temperature and stained
with 2% Giemsa for 30min. Bound IEwas counted using a Nikonmicro-
scope at 1000×magniﬁcation from six randomly selected distinct ﬁelds
in triplicate spots from three independent experiments. DMSO treated
cultures were used as controls to signify 100% binding.2.9. Quantitative measurement of PfMP-1 levels using BC6 monoclonal Ab
P. falciparum (A4 line) synchronized cultures (at least 3% trophozo-
ites) were incubated with FK506 (0.375; 0.75; 1.5 or 6 μM), calyculin
(2 or 10 μM), NFKKB inhibitor (1 or 2 μM) or DMSO (0.04%) for
30 min at 37 °C and washed in RPMI 1640 without serum. The pellet
was incubated with Plasmagel for enrichment of trophozoites and
washed again. Next, parasites were incubated with the BC6 antibody
(mouse IgG mAb directed against PfEMP-1), used at a dilution of 1:50
from 310 μg/ml stock in 1% BSA/PBS for 90 min at 37 °C, washed twice
in 1% BSA/PBS, centrifuged 2000 rpm for 5 min and the secondary anti-
body conjugated goat anti-mouse IgG-APC (1:100) (Thermo Scientiﬁc)
added followed by ethidium bromide 10 mg/ml (1:1000) in 1% BSA/
PBS for 90 min at 37 °C. The cells were washed twice in 1% BSA/PBS,centrifuged 2000 rpm for 5 min and ﬁxed in 0.5% paraformaldehyde/
PBS or BD CellFix (BD Biosciences) overnight at 4 °C.
For ﬂow cytometry analysis, stained infected cells were diluted in
PBS and 50,000 events acquired on a Beckman Coulter FACS XL ﬂow
cytometer, gated using forward scatter and side scatter signals to
acquire erythrocyte populations excluding debris and FL-1 and FL-2
ﬂuorescence intensity measured. Analysis was performed using FlowJo
software. Regions were drawn on density plots of uninfected controls
to gate uninfected cells such that b0.1% of the population fell into the re-
gion classed as ethidium bromide positive. This regionwas then used to
create a histogram. Region R1was created for A4 positive cells based on
negative antibody controls, b0.1% of the ethidium bromide positive
population fell into region R1 when no primary antibody was included.
Themean ﬂuorescence intensity (MFI) of region R1 was used to quanti-
tate the level of PfEMP-1 on A4 positive infected red blood cells.2.10. Statistical analysis
Results are expressed as mean ± SEM of at least three independent
experiments. Student’s t-test was used for comparisons between two
groups, whereas for repeated measures ANOVA was used for compari-
sons among larger groups. P value less than 0.05were considered indic-
ative of a statistically signiﬁcant difference. GraphPad Prism software
(version 5, San Diego, CA, USA) was used for all statistical tests.3. Results
TNF expression is known to be highly enhanced in P. falciparum
infection but its role during the asexual stage was not described. The
present work showed that TNF is of physiological importance in
Fig. 2. TNF intracellular calcium signalling can be blocked by P2X7 antagonist in P. falciparum isolated parasites labelled with Fluo4/AM (5 μM). (A) Analyses of Ca2+ concentration after
incubation with the purinergic inhibitor KN62 (10 μM) for 30min, A438079 (5 μM) for 2 min or thapsigargin (10 μM) all followed by addition of TNF (1 ng/ml) (2.15 a.u. ± 0.19, n=13,
P b 0.0001; 1.76 a.u. ± 0.24, n=11, P b 0.0001; or 1.236 a.u. ± 0.25; n=11, P b 0.0001, respectively). P values were calculated by comparison with the TNF (1 ng/ml) data (9.746 a.u. ±
1.03, n= 15). Bar graph means and SEM of at least three independent experiments. Arb. arbitrary. (B) Representative tracing of Fluo4/AM changes over time by addition of PBS, TNF
(1 ng/ml) and TNF (1 ng/ml) after incubation with KN62 (10 μM) or A438079 (5 μM) (C) Imaging of wheat germ agglutinin (WGA) staining in P. falciparum (3D7) saponin isolated
parasite after TNF (1 ng/ml) treatment for 1 h at 37 °C. Smears are stained with WGA (10 μg/ml for 10 min at 37 °C) and DAPI (1:1000 in PBS 15 min at RT) and observed by confocal
microscopy.
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invasion, similarly as previously described in the liver stages [25].
Parasites where incubated with TNF (1, 2 or 8 ng/ml at a ﬁnal
parasitemia of around 4% (3.98 a.u. ± 0.21, n = 9). We analyzed
possible changes in parasitemia and intra-erythrocytic development
by ﬂow cytometry (Fig. 1). Data indicate invasion reduction in the pres-
ence of 1 and 2 ng/ml TNF treatment with parasitemia being 13.11%
(±5.98 n = 8) and 12.72% (±9.4 n = 7) lower than untreated control
samples. Intra-erythrocytic parasite development was otherwise
similar for all other treatments (Fig. 1A and B). RepresentativeFig. 3. Extracellular calcium is required for TNF signalling in isolated P. falciparum labelled wi
(9.746 a.u. ± 1.03, n = 15) or incubation with the extracellular calcium chelator EGTA (5 m
0.371), EGTA (2 mM) (1.304 a.u. ± 0.038, n= 9, P = 0.001) or PBS treatment (0.989 a.u. ± 0
arbitrary. (B) Representative tracing of Fluo4/AM changes over time by addition of TNF (1 ng
and 5 mM, respectively).histogram showing ﬂow cytometry analysis of total parasitemia and
intra-erythrocytic stage distribution can be found at (Supplemental
material Fig. S4).
Next we veriﬁed the capacity of TNF to modulate calcium signaling
in P. falciparum parasites. For this purpose, saponin-isolated parasites
were incubated with Fluo-4/AM and spectroﬂuorimetric analyses
showed that TNF can increase free intracellular calcium concentration
([Ca2+]i) (Fig. 1C and D) with the highest transient increase observed
at 1 ng/ml. These quantities reﬂect typical values used in in vitro systems
but are towards the higher end of the physiological levels encounteredth Fluo4/AM (5 μM). (A) Analyses of Ca2+ concentration after addition of TNF (1 ng/ml)
M) for 1 min followed by addition of TNF (1 ng/ml) (1.002 a.u. ± 0.005, n = 11, P =
.016, n = 3). Bar graph means and SEM of at least three independent experiments. Arb.
/ml) or TNF (1 ng/ml) followed by thapsigargin (10 μM) after incubation with EGTA (2
Fig. 4. Expression of mRNA in synchronized trophozoites treated with TNF and 6-Bnz
cAMP in PfPCNA1. Real Time PCR for P. falciparum (3D7) control (PBS), TNF (1 ng/ml) or
6-Bnz-cAMP (20 mM), after incubation for 1 h at 37 °C. Bars represent mean ± S.E.M. in
3 independent experiments (P b 0.05*).
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in the plasma of patients with severe disease [30–31].
The use of kinase inhibitors has been explored for the control of
inﬂammation [15,32] and the inhibitor KN62 was previously shown to
modulate Plasmodium pathways [20–21]. Interestingly KN62 is a
Ca2+/calmodulin-dependent protein kinase II inhibitor and P2X7
antagonist that also blocked [Ca2+]i increase after TNF addition
(Fig. 2A & B), indicating the involvement of the pathways in TNFFig. 5. Effects of FK506 in Plasmodium-endothelial cell binding under ﬂow and static conditions
NFƘƘb inhibitor (2 μM), DMSO (0.04%) or no treatment of parasites under ﬂow assay showing
microvascular endothelial cells (HDMEC). (C) Adhesion of trophozoite-stage ItG IE to protein IC
ditions to ICAM1 showing bound IE per mm2 or (D) percentage of control (DMSO treated) bind
independent experiments (P b 0.05 *, P b 0.01 **, P b 0.001 ***) under ﬂow condition and no diffe
under static condition.signaling. Next A438079, a competitive P2X7 receptor antagonist also
inhibited the TNF/ IE response (Fig. 2A & B). Membrane integrity after
TNF treatment was studied following staining isolated parasites with
WGA by confocal microscopy imaging, revealing no effects of this factor
on membrane integrity, as WGA localization in the membrane was the
same for TNF-treated and control samples (Fig. 2C and Supplemental
data S1 and S2).
Plasmodium intracellular calcium homeostasis is known to be regu-
lated by endoplasmic reticulum (ER) among other organelles [33–34].
Here we showed using thapsigargin (THG) that the organelle is essen-
tial for the calcium response elicited by TNF as there is no response
after ER calcium depletion by THG (Fig. 2A & B).
Extracellular calcium can also be involved in intracellular ion
homeostasis so parasites were incubated with EGTA (2 or 5 mM). This
was capable of decreasing the calcium ion rise at a concentration of
2 mM, and completely abolished at 5 mM (Fig. 3). The parasite viability
during the experiment, in terms of its ability to respond, following THG
addition was conﬁrmed at the end of the experiment (Fig. 3).
As TNF reduces parasitemiawe have searched for a target thatmight
be involved in the control of cell cycle proliferation. A possible target in-
volved in the TNF response could be P. falciparum Proliferating-Cell Nu-
clear Antigen 1 (PfPCNA1), whichmay be differentially phosphorylated
by TNF treatment [35]. We have performed quantitative PCR to verify
the expression of PfPCNA1. Since TNF increases cytosolic calcium con-
centration in P. falciparum and calcium is well known to cross talk
with cAMP within several cells including malaria parasites [26–27] we
pre-treated P. falciparum not only with TNF but also with 6-Bnz cAMP.
According to Fig. 4, P. falciparum synchronized trophozoites treated. (A) Adhesion of trophozoite-stage A4 IE after FK506 (1.5 or 6 μM), calyculin (2 or 10 μM),
bound IE per mm2 or (B) percentage of control (DMSO treated) binding to human dermal
AM-1 after FK506 (0.375, 0.75 or 1.5 μM), DMSO (0.04%) or no treatment under static con-
ing. Bars represent mean ± S.E.M. Note differences in A4 erythrocyte binding among 3–5
rence observed in ItG erythrocyte binding among three independent treatments (P N 0.05)
Fig. 6. Analysis of PfEMP-1 expression on the surface of live trophozoite-stage A4 IE using BC6 antibody (A) Quantitation of PfEMP-1 levels by ﬂow cytometry analysis after BC6 primary
antibody (Alexa 488 coupled secondary antibody) and counterstaining infected erythrocyte with ethidium bromide. (B) Density plots of uninfected erythrocyte population in the left and
box IE (infected erythrocyte) representing BC6 positive erythrocytes (gated as ethidium bromide positive) (C) Representative graph showing quantitation of BC6 positive ﬂuorescence
intensity (X-axis APC-A) of the infected population without BC6 for negative control (red line); with BC6 and treated with DMSO 0.04% (black line) or (D) FK506 1.5 μM (black line)
treated A4 trophozoites. Bars represent mean ﬂuorescence intensity for PfEMP-1 positive population ± S.E.M. for 5 independent experiments. Note no difference in erythrocyte
PfEMP-1 quantitation levels (P N 0.05).
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mRNA expression in comparison to control treatments (PBS). The data
point to PfPCNA1 as a downstream target of the TNF–calcium–cAMP
signaling pathway, perhaps for reducing cell cycle proliferation, but
more work is needed to conﬁrm this. Other candidates studied (e.g.
PfRACK) showed no change upon TNF treatment (Supplemental data
— Fig. S3).
It is well established that inhibitors of TNF production reduced IE
cytoadherence [9–10]. As FK506 is a potent suppressor of inﬂammation
and the endothelial cell receptor ICAM-1 expression is increased by pro-
inﬂammatory cytokines [36], we have analyzed if FK506 inhibitor
would affect the P. falciparum binding under ﬂow and static conditions
to HDMEC.
Fig. 5(A and B) shows the results of experiments performed under
ﬂow conditions where parasites were ﬁrst treated with FK506 (1.5
and 6 μM), calyculin (2 and 10 μM) or Nfkkb inhibitor (2 μM). Higher
concentration of calyculin (10 μM) induced an increase in parasite bind-
ing indicating the involvement of phosphatases in cytoadherence.
While at higher concentration FK506 (6 μM) and Nfkkb inhibitor
(2 μM) showed a decrease in binding to HDMEC and highlight the po-
tential importance of the host immune response on parasite signaling
and sequential binding to endothelial cells. Under static protein assays
(Fig. 5C and D) reduction in binding was not statistically different be-
tween FK506 at lower concentrations (0.375, 0.75 or 1.5 μM) compared
to the controls, DMSO (0.04 %) or untreated parasites.To determine whether the ability of parasites (treated as described
in Fig. 5) to adhere was due to PfEMP-1 expression on the infected
erythrocyte membrane we performed ﬂow cytometry measurements
using mAb BC6, speciﬁc for a surface epitope of the PfEMP-1 ITvar14
(A4var) variant [37]. The results clearly demonstrate that PfEMP-1
expression is not changed under the treatments (Fig. 6).
4. Discussion
TNF is known to be involved in immunological response and
required for defense against infectious diseases [38]. During Plasmodium
inﬂammation TNF concentration in the serum increases at pmol range,
speciﬁcally reported in patients with P. falciparum, P. vivax malaria
infection and healthy controls that average plasma TNF levels are
0.027 ng/ml, 0.044 ng/ml and 0 ng/ml, respectively [39].
More recently plasma TNF level was determined by enzyme-linked
immunosorbent assay in malaria naive donors and P. vivax
infected donors indicating its concentration increases in infected
samples up to about 1000 pg/ml [17]. The difference in TNF plasma
concentration among patients can be due to host genetic alterations
which inﬂuence levels of inﬂammatory mediators [16]. We examined
the effect of extracellular TNF concentration in modulating
P. falciparum intracellular development and its molecular mechanism
of action. TNF receptors are well characterized in mammalian cells but
not described in Plasmodium [15]. The effects of recombinant TNF in
Fig. 7. Schematicmodel for themolecularmechanism of TNF action by calcium signaling on Plasmodium inhibition of intraerythrocytic cell cycle. Extracellular TNF (tumor necrosis factor)
binds andmodulates a putative ATP receptor (ATP-R) at the parasitemembrane (PM), leading to intracellular calcium rise. The parasite hasmechanisms to dealwith calcium homeostasis
such as: endoplasmic reticulum (ER), mitochondria (Mit) and acidic pools (AC) or via inﬂux of extracellular calcium by the capacitative calcium entry (CCE). Cyclic adenosine
monophosphate (cAMP) is able to promote further calcium increase from the ER while its concentration in the cytosol is regulated by Ca2+, adenylyl cyclase (AC) and
phosphodiesterase (PDE). Ca2+ concentration in the parasite cytosol modulates several downstream effectors such as calmodulin (cAM), calcium-dependent protein kinases (CDPKs),
proteases activation and possibly targeting gene expression (such as PCNA1) which can act by inhibiting the intracellular parasite cell cycle.
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in vitro and in vivo already showed reduced parasitaemia and prolonged
survival in mice infected. The authors indicated that TNF acts thought a
host cell pathway [40].
The present work showed that TNF is of physiological importance in
Plasmodium as it was able to modulate Plasmodium intra-erythrocytic
invasion and to increase [Ca2+]i with the highest effect observed at
TNF 1 ng/ml, indicating sensitivity to this cytokine (Fig. 1).
Ion homeostasis and the presence of a classical endo-sarcoplasmic
reticulum Ca2+ ATPase which can be blocked by THG causing calcium
release and reversible mitochondrial calcium increase is well reported
including Plasmodium [33,41–43]. Thus the importance of external and
intracellular calciumstores in TNF pathwayswas also highlighted by ex-
periments with addition of THG or EGTA incubation, as both inhibited
the [Ca2+]i rise due to TNF (Figs. 2 and 3).
Increase in cytoplasmic calcium was previously shown to synchro-
nize Plasmodium cell cycle [44] and the cAMP analogue (adenosine
3,5-cyclic monophosphate N6-benzoyl (6-Bz-cAMP) caused alteration
of the parasite cell cycle, possibly dependent on PKA activation [26].
These ﬁndings suggest that the TNF response requires a tightly
controlled calcium dependent pathway.
The ability of the parasite to use calcium for signaling and to sense
the environment was linked to the process of Plasmodium synchronicity
and host circadian rhythms [45] and veriﬁed by experiments in the
presence of melatonin, other products of tryptophan catabolism and
melatonin degradation indicating the presence of a PLC-IP3 mechanism
evoked by calcium mobilization [46–49] and described a “capacitative
calcium entry” mechanism to replenish internal calcium pools in
Plasmodium [50].To better understand this TNF pathway in parasites the increase in
intracellular calcium was analyzed after incubation with the purinergic
P2X7 receptor antagonists KN62 and A438079. Interestingly, both
compounds inhibited [Ca2+]i elevations induced by TNF (Fig. 2). Indeed
the P2X7 receptor has been identiﬁed as a down-stream target of TNF
actions, shown in the work of Castrichini et al. [19], exploring the
pathophysiology of this purinergic receptor in Behçet's disease [19].
The authors of this work showed that incubation of monocytes resulted
in an increase of P2X7 receptor expression and Bz-ATP calcium inﬂux. In
view of that, the TNF-triggered calcium ﬂuxes are supposed indirect
actions, involving TNF-induced P2X7 receptor activation, which then
opens receptor channels for calcium ﬂux. Mammalian cells are
described to form P2X1–P2X7 ATP-gated ion channels permeable to
Ca2+ among other ions, while the P2X7 receptor intracellular domain
couple receptor activation to intracellular signaling pathways [51–53].
In Plasmodium it was previously shown that KN62 inhibited
P. falciparum invasion and [Ca2+]i rises due to stimulation by extracellu-
lar ATP [21], and in P. berghei KN62 altered proﬁles of merozoite surface
protein 1 processing and cell cycle progress [20]. Changes in [Ca2+]i also
elicited cysteine proteases activity in the parasite [34,54]. Previouswork
has already suggested inter-relationships for TNF-P2X7 receptor signal-
ing in other cellular contexts, such as P2X7 receptor expressionmodula-
tion in immune cells in Behçet's disease [19] or the P2X7 receptor-
dependent regulation of TNF release in microglial cells [18] (Further
work will elucidate the context of P2X7 receptor–TNF interactions in
the biology of P. falciparum.
Interestingly expression of PfPCNA1, which encodes the proliferat-
ing cell nuclear antigen-1, a key factor for DNA polymerase on the lead-
ing strand and plays accessory roles in DNA replication/repair [55–57],
1496 L.N. Cruz et al. / Biochimica et Biophysica Acta 1860 (2016) 1489–1497decreased after treatment with TNF (1 ng/ml) or 6-Bnz cAMP (20 μM)
indicating PfPCNA1 as a potential target of the pathway.
Experiments to verify the inﬂuence of immune/ inﬂammation
response to parasite cytoadherence indicated a change in binding to
HDMEC after treating parasites with the immunosuppressant FK506
or Nfkkb inhibitor. Results highlighted the importance of host immune
response on parasite signalling, providing an important link that
needs to be better characterized in further studies.
A possible hypothesismight be that TNF is inducing intracellular cal-
cium increase, which includes molecules targeting upstream signalling
events involved in cellular responses by the parasite. The proteins trans-
ducing these signals to the parasite nucleus are not known, although
published data from our group [35] suggests that phosphorylation of a
sub-population of PfPCNA1 may be involved. Our pathway hypothesis
is shown in Fig. 7.
The present work indicates that intracellular calcium concentration
can bemodulated by external TNF treatment of the IE and the pathway’s
biological importance indicated by the modulation of P. falciparum
erythrocyte invasion. Moreover, our data shows that Plasmodium sub-
verts the immunological system and uses TNF for the control of its pro-
liferation within the vertebrate host.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2016.04.003.
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